Project

Phase 3 Study of Teclistamab in Combination with Lenalidomide versus Lenalidomide Alone in Participants with Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Ongoing - recruitment active · 2022 until 2030

Silzle Tobias, Scherrer Julia, Frehner Jan